Mathieu Vinken (Belgian; born 1 February 1978) is a professor affiliated with the Department of Pharmaceutical and Pharmacological Sciences at the Faculty of Medicine and Pharmacy of the Vrije Universiteit Brussel-Belgium and a visiting professor at the Department of Pathology of the Faculty of Veterinary Sciences of the University of São Paulo-Brazil. He has a master degree in pharmaceutical sciences (Pharm.D.), holds a doctoral degree in in vitro toxicology (Ph.D.), is a European registered toxicologist (E.R.T.) and a trained European chemical risk assessor. His research focuses on 2 topics, namely (i) the study of mechanisms of liver toxicity to be used for in vitro modelling purposes as well as for prediction of chemical-induced liver toxicity, and (ii) the study of connexins and pannexins as drug targets and diagnostic biomarkers of liver disease. He acquired over €20 million external funding, of which most as promoter and a large portion originating from the European Horizon 2020 excellent science pillar, namely 2 grants (i.e. starting grant and proof-of-concept grant) from the European Research Council (ERC), 1 grant from the Future and Emerging Technologies (FET) program and 1 grant from the Marie Skłodowska-Curie Actions (MSCA) program, as well as national excellent research funding, including from the Flemish Methusalem program and a São Paulo excellence chair grant. He coordinates several (inter)national research projects, among which the 5-years European project called “ONTOX: ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment” (€17 million; 18 European and US partners). He is a regular member of 7 scientific societies in the area of toxicology and hepatology. He is past-president and honorary member of the European Society of Toxicology In Vitro (ESTIV), former steering committee member of the Belgian society of Toxicology (BelTox) and current chair of the In Vitro and In Silico Toxicology Speciality Section of the Association of European Toxicologists and European Societies of Toxicology (EUROTOX). He is a frequently consulted toxicologist by European agencies (i.e. European Food Safety Authority), industry (i.e. Cosmetics Europe) and high-impact factor journals (i.e. Science). He is a regularly invited speaker on international and world conferences. He is promoter of 6 completed and 10 ongoing doctoral projects as well as of 3 completed and 6 ongoing postdoctoral projects. He is author of as much as 200 publications in international peer-reviewed journals (h-index in Web of Science: 43) and books. He is editor of 3 books. He is editor-in-chief of the journals Toxicology, Frontiers in In Vitro Toxicology and MethodsX Pharmacology, Toxicology and Pharmaceutical Science, European editor of Applied In Vitro Toxicology, and associate editor of Current Research in Toxicology, Archives of Toxicology and Journal of Dietary Supplements. He received 10 scientific awards, among which the Galen Award for Pharmacology.

- ORCID ID: 0000-0001-5115-8893

- Researcher ID: H-7513-2013

- Website: www.mathieuvinken.com